GenSight Biologics logo

GenSight Biologics

Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases

34 employees · est. 2013 · Paris, France

VS
Ray Therapeutics, Inc. logo

Ray Therapeutics, Inc.

Optogenetic Gene Therapy Company

46 employees · est. 2021 · Berkeley, United States

GenSight Biologics is the older company (2013 vs 2021).

Side-by-Side Comparison

GenSight Biologics Ray Therapeutics, Inc.
Founded
2013 older 2021
Headquarters
Paris, France Berkeley, United States
Employees
34 46
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Post Ipo Equity Series B
Total Funding
$245.64M $235.00M
Funding Rounds
17 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical-stage Biotech, Gene Therapy, Retinal Diseases, Neurodegenerative Diseases, Mitochondrial Targeting Sequence, Optogenetics, Retinitis Pigmentosa, LHON, Gene Therapy-Based Treatments, Intravitreal Injection, Vision Restoration, Retinal Degeneration, Rare Diseases, Innovative Therapies Optogenetic Gene Therapy, Vision Restoration, Retinal Blindness, Age-related Macular Degeneration, Retinitis Pigmentosa, ChRown Optogenetic Protein, AAV Gene Therapy, Precision Therapy, Clinical Trials, Gene Therapy Manufacturer, Visual Acuity, Contrast Sensitivity, Visual Field, Preclinical Stage
Website
gensight-biologics.com raytherapeutics.com
GenSight Biologics logo

About GenSight Biologics

GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and optogenetics, the company is striving to preserve or restore vision in patients with degenerative reti...

Ray Therapeutics, Inc. logo

About Ray Therapeutics, Inc.

Ray Therapeutics, Inc. (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Their studies have shown for the fir...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at GenSight Biologics and Ray Therapeutics, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at GenSight Biologics and Ray Therapeutics, Inc. — by email.

Frequently Asked Questions

GenSight Biologics — Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases. Ray Therapeutics, Inc. — Optogenetic Gene Therapy Company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
GenSight Biologics has raised $245.64M while Ray Therapeutics, Inc. has raised $235.00M.
GenSight Biologics and Ray Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare GenSight Biologics with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy